Jilin Province Lefu Biotechnology Co., Ltd. – Trademark Portfolio

Entity Type: 16

Jilin Province Lefu Biotechnology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include AESCULIX. The owner is based in Changchun.

4th Floor, No. 816-1, Pudong Road

Economic Development Zone

Changchun 130000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AESCULIX
AESCULIX
Registered 2025

Trademark Classifications

Jilin Province Lefu Biotechnology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Jilin Province Lefu Biotechnology Co., Ltd. have?

Jilin Province Lefu Biotechnology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Jilin Province Lefu Biotechnology Co., Ltd. file in?

Jilin Province Lefu Biotechnology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 1 (Chemicals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Jilin Province Lefu Biotechnology Co., Ltd.'s most well-known trademarks?

Jilin Province Lefu Biotechnology Co., Ltd.'s registered trademark portfolio includes well-known marks such as AESCULIX. These are among 1 currently registered trademark in the portfolio.

What is Jilin Province Lefu Biotechnology Co., Ltd.'s trademark registration success rate?

Jilin Province Lefu Biotechnology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.